Survival Benefit, Toxic Profile, Cost Effectiveness in Patients Treated with 5 Fluoropyrimidine and Capecitabine for Colorectal Cancer in Adjuvant Setting
JavaScript is disabled for your browser. Some features of this site may not work without it.
Survival Benefit, Toxic Profile, Cost Effectiveness in Patients Treated with 5 Fluoropyrimidine and Capecitabine for Colorectal Cancer in Adjuvant Setting